In several pilot studies, transcranial brain sonography findings of substantia nigra and lenticular nucleus discriminated between idiopathic Parkinson disease (PD) and atypical parkinsonian disorders.
I
DIOPATHIC PARKINSON DISEASE (PD) and atypical parkinsonian syndromes such as the parkinsonian variant of multiple-system atrophy (MSA-P) and progressive supranuclear palsy (PSP) differ in their prognosis and treatment options but may be difficult to differentiate clinically, especially in the early course of the disease.
1,2 Also, levodopa sensitivity is not always conclusive in differentiating these diseases. Sophisticated neuroimaging methods such as routine magnetic resonance imaging, singlephoton emission computed tomography, and positron emission tomography may help to discriminate between PD and atypical parkinsonian syndromes. Despite the high technical demands and costs of these techniques, sensitivity and specificity are not sufficiently high. 3, 4 Recently, transcranial brain sonography (TCS) was reported to discriminate PD from MSA-P and PSP. 5, 6 The TCS finding of substantia nigra hyperechogenicity is characteristic of PD, [5] [6] [7] [8] [9] whereas normal substantia nigra echogenicity in combination with lenticular nucleus hyperechogenicity suggests atypical parkinsonian syndromes. 5, 6, 10 Substantia nigra hyperechogenicity is thought to reflect increased amounts of iron, bound to proteins other than ferritin in the substantia nigra, and remains unchanged during the course of PD. [11] [12] [13] Also, lenticular nucleus hyperechogenicity is most likely to be caused by increased trace metal content. 5, 14, 15 Because patients with PD and substantia nigra hyperechogenicity (Ͼ90% of all patients with PD) were found to have a younger age at disease onset (mean ± SD, 54 ± 7 years) compared with patients with PD and normal substantia nigra echogenicity (Ͻ10%; mean± SD, 65 ± 6 years), 7 we hypothesized that sonographic discrimination from atypical parkinsonian syndromes might be clearer in patients with PD who have onset at younger than 60 years compared with patients with later PD onset. To further assess the discriminative value of TCS, we studied a larger group of patients with PD, randomly mixed with patients with MSA-P or PSP.
METHODS

STUDY POPULATION
We prospectively studied all patients with sporadic parkinsonism admitted to our movement disorder clinic from January 1, 2003, through December 31, 2005, who fulfilled the British Brain Bank criteria for definite PD 16 or the clinical consensus criteria for probable MSA-P or PSP. 1, 17 Computed tomography and/or magnetic resonance imaging of the brain and laboratory workup were performed in all patients to exclude other causes of parkinsonism. Altogether, we included the following 181 patients: 138 with idiopathic PD, 21 with MSA-P, and 22 with PSP. Fifty-nine patients with PD had disease onset at younger than 60 years (PD60 − patients), and 79, at 60 years or older (PD60 ϩ patients). The TCS findings of some of these patients (PD60 − , n=10; PD60 ϩ , n=15; MSA, n=9; PSP, n=6) had contributed to results of a previously published study.
5 Table 1 shows demographic data of the patients studied.
TRANSCRANIAL BRAIN SONOGRAPHY
We performed TCS through the preauricular acoustic bone windows using a phased-array ultrasound system with a 2.5-MHz transducer (Sonoline; Siemens, Erlangen, Germany). The ultrasound variables chosen were penetration depth of 16 cm, dynamic range of 50 dB, and high persistence. Substantia nigra echogenic size measurements were performed on axial TCS images automatically after manually encircling the outer circumference of the echogenic area of the substantia nigra. According to the normal values of substantia nigra echogenic size, obtained by examining 300 healthy adults, the substantia nigra echogenicity was classified into the following 3 groups: group 1, normal substantia nigra echogenicity (echogenic size, Ͻ75th percentile of the healthy control group, ie, Ͻ0.20 cm 2 ); group 2, moderate substantia nigra hyperechogenicity (echogenic size, 75th-90th percentile); and group 3, marked substantia nigra hyperechogenicity (echogenic size, Ͼ90th percentile, ie, Ն0.25 cm 2 ). 5, 7 For classification of patients with respect to their substantia nigra echogenicity, the greater value of bilateral measurements was used. For intergroup comparisons, bilateral substantia nigra echogenic sizes in each individual were used. In addition, echogenicity of the lenticular nucleus was investigated and classified as hyperechogenic when it was more intense than the surrounding white matter. 5, 6 Classification of patients with respect to lenticular nucleus echogenicity was based on the more affected side. Because third-ventricle dilatation was previously reported as a TCS finding characteristic of PSP, 10 In the patients with sufficient temporal acoustic bone windows, moderate or marked substantia nigra hyperechogenicity was found in all PD60 − patients, 74 PD60 ϩ patients (96%), 2 patients with MSA-P (10%), and 9 patients with PSP (47%) (Figure 1 and Figure 2 ). Substantia nigra echogenic sizes were larger in patients with PD than in those with MSA-P (MannWhitney test, PϽ.001) and PSP (PϽ.001). There was no correlation of substantia nigra echogenic sizes with age, disease severity, or disease duration in either group (Spearman rank correlation coefficients). Because the PD60 − patients had a mean disease duration 3 times longer than that of those with MSA-P and PSP, we also compared substantia nigra echogenic sizes of PD60 − patients with a PD duration of no longer than 5 years and those with a PD duration of longer than 5 years and did not find a difference (Spearman rank correlation, P = .20). The finding of normal substantia nigra echogenicity indicated the clinical diagnosis of MSA-P or PSP (ie, not being diagnosed as having PD) with a positive predictive value of 91% ( Table 2) . Normal substantia nigra echogenicity best discriminated MSA-P from PD (sensitivity, 90%; specificity, 98%; positive predictive value, 86%). In patients with assessable windows and onset of parkinsonism at younger than 60 years (PD60 − , n=57; MSA-P, n=10; PSP, n=2), normal substantia nigra echogenicity indicated MSA-P or PSP with a positive predictive value of 100%.
Lenticular nucleus hyperechogenicity was found in 10 PD60
− patients (19%), 21 PD60 ϩ patients (30%), 15 patients with MSA-P (75%), and 19 patients with PSP (100%). The patients with PD with and without lenticular nucleus hyperechogenicity did not differ with respect to disease duration, disease severity, age at PD onset, or motor subtype. Lenticular nucleus hyperechogenicity in combination with normal substantia nigra echogenicity was detected only in 13 patients with MSA-P (65%) and 10 patients with PSP (53%) (Figure 3) . Lenticular nucleus hyperechogenicity in combination with normal or moderately hyperechogenic substantia nigra was seen in none of the PD60 − patients, 4 PD60 ϩ patients (6%), 15 patients with PSP (79%), and 15 patients with MSA-P (75%). Third-ventricle dilatation of more than 10 mm was found in 5 PD60 − patients (9%), 9 PD60
ϩ patients (12%), 4 patients with MSA-P (21%), and 17 patients with PSP (85%). Combination of thirdventricle width of more than 10 mm with lenticular nucleus hyperechogenicity was exhibited in 1 PD60 − patient (2%), 1 PD60 ϩ patient (1%), 4 patients with MSA-P (21%), and 16 patients with PSP (84%) (Figure 4 and Figure 5 ). Third-ventricle width of more than 10 mm in combination with hyperechogenic lenticular nucleus discriminated PSP from PD with a positive predictive value of 89% (sensitivity, 84%; specificity, 98%). The finding of hyperechogenic lenticular nucleus in combination with normal echogenic substantia nigra or third-ventricle dilatation of more than 10 mm indicated MSA-P or PSP rather than PD, with a positive predictive value of 94% ( Table 2) .
The flow diagram in Figure 6 displays the diagnostic algorithm and accuracy of substantia nigra and lenticular nucleus TCS for excluding the diagnosis of idiopathic PD in patients with sporadic parkinsonism.
COMMENT
Data obtained in this study show that the combined TCS finding of normal substantia nigra echogenicity and lenticular nucleus hyperechogenicity excludes the diagnosis of PD, indicating MSA-P or PSP, with a positive predictive value of 100%. In patients with onset of parkinsonism at younger than 60 years, normal substantia nigra echogenicity alone indicates MSA-P or PSP rather than PD, with a sensitivity of 75% and a positive predictive value of 100%. We found that MSA-P is best discriminated from PD by normal substantia nigra echogenicity, whereas PSP is best discriminated from PD by the combined finding of third-ventricle dilatation of more than 10 mm and lenticular nucleus hyperechogenicity. A limitation of this study is that the diagnosis of MSA-P or PSP in our patients could not be confirmed by postmortem investigation, which is the diagnostic gold standard. We aimed to minimize the liability of a misdiagnosis by including only patients with clinically probable MSA-P or PSP according to current consensus criteria. 1, 17 On the basis of the findings of 2 pilot studies that identified the substantia nigra, lenticular nucleus, and third ventricle as the brain structures of most value for sonographic syndrome discrimination, 5, 10 in the present study these structures were systematically studied in a large sample of patients. In a recent study, only the substantia nigra and lenticular nucleus were investigated, and patients with clinically possible MSA-P and PSP were included. 6 Frequency and distribution of TCS abnormalities of the substantia nigra, lenticular nucleus, and third ventricle found in the present study are in line with previous findings in patients with PD, MSA-P, and PSP. [5] [6] [7] [8] [9] [10] The group of patients with PD was subdivided according to onset of parkinsonism before 60 years or at 60 years or older because this cutoff value was found to differentiate patients with PD who had normal and hyperechogenic substantia nigra. 7 Our hypothesis, namely that in parkinsonian patients with age at onset younger than 60 years, the value of normal substantia nigra echogenicity in predicting MSA-P or PSP is higher than in patients with later onset, was confirmed by the present findings. Substantia nigra echogenicity in our patients with PD was independent of disease duration, which agrees with the findings of a previously reported 5-year follow-up study that demonstrated stable substantia nigra echogenic sizes in patients with PD. 12 In recent studies, normal substantia nigra echogenicity also separated posttraumatic parkinsonism and essential tremor from idiopathic PD. 18, 19 However, the value of substantia nigra hyperechogenicity alone in predicting the diagnosis of idiopathic PD in parkinsonian patients is less specific because substantia nigra hyperechogenicity is also frequent in patients with corticobasal degeneration, 10 dementia with Lewy bodies, 20 and parkin-related hereditary parkinsonism. 21, 22 In these entities, the additional TCS findings of more pronounced and bilateral symmetric substantia nigra hyperechogenicity or of lenticular nucleus hyperechogenicity may be obtained and may help to discriminate them from PD. 10, 20 Data in this study suggest that distinct TCS findings in parkinsonian patients indicate an atypical parkinsonian syndrome rather than PD, with a high positive predictive value. Further studies are necessary that compare TCS findings with postmortem histopathological findings in parkinsonian patients. As TCS has the advantages of wide availability, noninvasiveness, and short investigation times, this method might become useful to improve diagnostic accuracy.
